Table: Ono Pharm -6-MTH group results (IFRS)

ONO PHARMACEUTICAL

01/11/2023 03:00

Nov 1 (Reuters)- 
              Ono Pharmaceutical Co Ltd 
              CONSOLIDATED FINANCIAL HIGHLIGHTS 
     (in billions of yen unless specified) 
                   6 months ended      6 months ended       Year to 
                  Sep 30, 2023        Sep 30, 2022     Mar 31, 2024 
                     LATEST             YEAR-AGO          COMPANY   
                     RESULTS             RESULT          FORECAST   
  Sales              258.71              216.70           500.00    
                   (+19.4 pct)         (+24.5 pct)      (+11.8 pct) 
  Operating           97.04               80.27           167.00    
                   (+20.9 pct)         (+38.0 pct)      (+17.6 pct) 
  Pretax              99.30               81.02           169.00    
                   (+22.6 pct)         (+36.8 pct)      (+17.7 pct) 
  Net                 74.49               62.34           126.00    
                   (+19.5 pct)         (+34.7 pct)      (+11.8 pct) 
  EPS Basic        153.33 yen          127.67 yen       259.36 yen  
  EPS Diluted      153.32 yen          127.66 yen                   
  Ann Div                               70.00 yen        80.00 yen  
  -Q2 Div           40.00 yen           33.00 yen                   
  -Q4 Div                               37.00 yen        40.00 yen  
 
  NOTE - Ono Pharmaceutical Co Ltd. 
  (Figures are reported based on international accounting rules (IFRS).) 
  If there is no Q1 or Q3 dividend, Q2 will in most cases correspond to the first-half 
  dividend and Q4 to the second-half dividend announced before a new corporate law in 
  2006 allowed companies to pay and report dividends on a quarterly basis.
  *Net - represents Net profit attributable to owners of the parent company. 
  To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4528.T